Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100045254Phase 4Recruiting
Phase 4, randomised, double-blind trial of nitroglycerin in ischemic stroke (2 arms), sponsored by Beijing Luhe Hospital. Primary endpoint: Symptomatic intracranial hemorrhage. Started Jan 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100045254.